BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 25636956)

  • 1. Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma.
    Ma L; Ji L; Yu Y; Wang J
    Discov Med; 2015 Jan; 19(102):7-14. PubMed ID: 25636956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW; Poon RT
    Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy of hepatocellular cancer.
    Wysocki PJ
    Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
    Wang X; Zhang A; Sun H
    Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma.
    Frau M; Biasi F; Feo F; Pascale RM
    Mol Aspects Med; 2010 Apr; 31(2):179-93. PubMed ID: 20176048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatocellular carcinoma].
    Semela D; Heim M
    Ther Umsch; 2011 Apr; 68(4):213-7. PubMed ID: 21452143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics for the early detection and treatment of hepatocellular carcinoma.
    Feng JT; Shang S; Beretta L
    Oncogene; 2006 Jun; 25(27):3810-7. PubMed ID: 16799622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dimensional biology to comprehend hepatocellular carcinoma.
    Vivekanandan P; Singh OV
    Expert Rev Proteomics; 2008 Feb; 5(1):45-60. PubMed ID: 18282123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
    Kudo M
    Dig Dis; 2011; 29(3):273-7. PubMed ID: 21829017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging targeted strategies in advanced hepatocellular carcinoma.
    Finn RS
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S11-9. PubMed ID: 23457035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular cancer in the non-cirrhotic liver.
    Alkofer B; Lepennec V; Chiche L
    J Visc Surg; 2011 Feb; 148(1):3-11. PubMed ID: 21306970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
    Dahmani R; Just PA; Perret C
    Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):709-13. PubMed ID: 21778132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signature of early hepatocellular carcinoma.
    Suriawinata A; Thung SN
    Oncology; 2010 Jul; 78 Suppl 1():36-9. PubMed ID: 20616582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New possibilities in hepatocellular carcinoma treatment.
    Rasool M; Rashid S; Arooj M; Ansari SA; Khan KM; Malik A; Naseer MI; Zahid S; Manan A; Asif M; Razzaq Z; Ashraf S; Qazi MH; Iqbal Z; Gan SH; Kamal MA; Sheikh IA
    Anticancer Res; 2014 Apr; 34(4):1563-71. PubMed ID: 24692683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma.
    Jiang T; Zhu AX; Sahani DV
    J Hepatol; 2013 Jan; 58(1):169-77. PubMed ID: 22944253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma: important biomarkers and their significance in molecular diagnostics and therapy.
    Sengupta B; Siddiqi SA
    Curr Med Chem; 2012; 19(22):3722-9. PubMed ID: 22680921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma.
    Fatima S; Luk JM; Poon RT; Lee NP
    Expert Rev Mol Diagn; 2014 Jun; 14(5):535-48. PubMed ID: 24809435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in tumor markers of human hepatocellular carcinoma.
    Yoon SK
    Intervirology; 2008; 51 Suppl 1():34-41. PubMed ID: 18544946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Met as a therapeutic target in HCC: facts and hopes.
    Giordano S; Columbano A
    J Hepatol; 2014 Feb; 60(2):442-52. PubMed ID: 24045150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.